CONMED
CNMDCONMED Corporation is a medical technology company that specializes in the development and manufacture of surgical devices and equipment.
Earnings
Q3 2026 report
October 28, 2026Next report
Jan 27, 2027 (in 3 months)Valuation & ratios
Segments
Competitors
By market cap
By revenue growth
Profile
CONMED Corporation is a medical technology company that specializes in the development and manufacture of surgical devices and equipment. The company provides innovative solutions for minimally invasive procedures across specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Its core value proposition centers on improving patient outcomes through high-quality surgical tools, visualization systems, and tissue repair technologies distributed globally.
CONMED is a leading provider of specialized surgical equipment, particularly in the niche markets of insufflation and smoke evacuation, while maintaining a strong recurring revenue base through single-use disposables.
FAQ
- What is CONMED's market cap?
- CONMED (CNMD) has a market capitalization of $1.3B and trades on NYSE.
- What is CONMED's revenue and profitability?
- CONMED generated $1.4B in trailing twelve-month revenue with net income of $73.4M, representing a net margin of 5.4%. Gross margin stands at 57.6%, with free cash flow of $132.7M. The latest reported period is Q3 2026.
- Who are CONMED's competitors?
- CONMED's key competitors include Stryker Corporation, Vericel Corporation, Boston Scientific Corporation, and others. These companies compete in similar markets and product categories.
- Who does CONMED partner with?
- CONMED's notable partners include W. L. Gore & Associates, Inc., Gallup.
- What subsidiaries does CONMED have?
- CONMED's subsidiaries include Buffalo Filter, LLC, Linvatec Corporation.
- Where is CONMED headquartered?
- CONMED is headquartered in United States of America and employs approximately 4,000 people. It has been publicly traded since 1987.
